UMIN-CTR Clinical Trial

Recruitment status Completed
Unique ID issued by UMIN UMIN000014931
Receipt No. R000017374
Scientific Title slow specific oral torerance induction used by low allegen cookies for egg allergy
Date of disclosure of the study information 2014/08/23
Last modified on 2020/06/12 (Ver. 2)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title slow specific oral torerance induction used by low allegen cookies for egg allergy
Acronym slow specific oral torerance induction used by low allegen cookies
Scientific Title slow specific oral torerance induction used by low allegen cookies for egg allergy
Scientific Title:Acronym slow specific oral torerance induction used by low allegen cookies
Region
Japan

Condition
Condition egg allergy patient
Classification by specialty
Pediatrics
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 effcacy of slow specific oral tolerance inductinon used by low allergen cookies
Basic objectives2 Safety,Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes the number of starting to eat more than 0.5g egg white without any symptoms after 4 months oral tolerance inductions
Key secondary outcomes

Base
Study type Interventional

Study design
Basic design Parallel
Randomization Randomized
Randomization unit Individual
Blinding Double blind -all involved are blinded
Control Placebo
Stratification YES
Dynamic allocation YES
Institution consideration
Blocking
Concealment

Intervention
No. of arms 2
Purpose of intervention Treatment
Type of intervention
Food
Interventions/Control_1 oral immunnotherapy by low allergen cookies
Interventions/Control_2 oral immunnotherapy by plasebo cookies
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
1 years-old <=
Age-upper limit
12 years-old >=
Gender Male and Female
Key inclusion criteria patients unable to eat more than 0.5g egg white by the positive result of oral egg white challenge test
Key exclusion criteria patients able to eat more than 0.5g egg white by the result of oral egg white challenge test
Target sample size 30

Research contact person
Name of lead principal investigator
1st name
Middle name
Last name yuri takaoka
Organization osaka prefectual hospital organization osaka prefectural medical center for respiratory and allergic diseases
Division name department of pediatrics
Zip code
Address 3-7-1 habikino habikino city osaka583-8588japan
TEL 072-957-2121
Email takaokayu@ra.opho.jp

Public contact
Name of contact person
1st name
Middle name
Last name yuri takaoka
Organization osaka prefectual hospital organization osaka prefectural medical center for respiratory and allergic
Division name department of pediatrics
Zip code
Address 3-7-1 habikino habikino city osaka583-8588japan
TEL 072-957-2121
Homepage URL
Email takaokayu@ra.opho.jp

Sponsor
Institute osaka prefectual hospital organization osaka prefectural medical center for respiratory and allergic diseases
Institute
Department

Funding Source
Organization none
Organization
Division
Category of Funding Organization Other
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

IRB Contact (For public release)
Organization
Address
Tel
Email

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2014 Year 08 Month 23 Day

Related information
URL releasing protocol
Publication of results Unpublished

Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status Completed
Date of protocol fixation
2014 Year 07 Month 01 Day
Date of IRB
2014 Year 02 Month 06 Day
Anticipated trial start date
2014 Year 07 Month 28 Day
Last follow-up date
2018 Year 12 Month 31 Day
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Other
Other related information

Management information
Registered date
2014 Year 08 Month 23 Day
Last modified on
2020 Year 06 Month 12 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000017374